EDGAR·FLOW

HERON THERAPEUTICS, INC. /DE/ — Form 8-K

Filed November 9, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 92/100
What the filing says
Heron Therapeutics announced Q3 2026 net revenue of $35.3M (down 7.8% from $38.2M in Q3 2025), with ZYNRELEF up 13.8% and APONVIE up 49.3% YoY, but CINVANTI down 16.6%. More significantly, the company entered into a definitive asset purchase agreement whereby CorMedix Therapeutics will acquire substantially all of Heron's assets, subject to stockholder approval and customary closing conditions. Heron ended Q3 with $23.4M in cash and equivalents, and commercial sales of SUSTOL ceased September 30, 2026.
Why this rating

Asset sale represents existential change—company ceasing independent operations. $235M market cap company being acquired whole. Highly significant regardless of deal terms.

Tradability signal
NO TRADE

No trade: price $0.38 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
before filing · preread
$0.38 ▲ 2.06%
at our read · unknown
$0.37
+10 min · unknown
$0.39 ▲ 5.42%
+30 min · unknown
$0.37 ▲ 1.36%
+1 hr · unknown
$0.39 ▲ 5.15%
+4 hrs · unknown
$0.38 ▲ 2.98%

The stock had already moved -2.02% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ HRTX · stock on Yahoo Finance ↗

See more from November 9, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.